General MedicationsINJECTIONStandard

STREPTOMYCIN SULFATE

Standard Dose

EQ 1GM BASE/VIAL

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Prescription

Summary

Approval overview STREPTOMYCIN SULFATE is listed in Drugs@FDA under application 064210 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient STREPTOMYCIN SULFATE Form and strength INJECTABLE;INJECTION - EQ 1GM BASE/VIAL Sponsor XGEN PHARMS Submission history Latest submission status date: 2023-02-10 00:00:00.

Structured Monograph

Clinical summary

Approval overview STREPTOMYCIN SULFATE is listed in Drugs@FDA under application 064210 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient STREPTOMYCIN SULFATE Form and strength INJECTABLE;INJECTION - EQ 1GM BASE/VIAL Sponsor XGEN PHARMS Submission history Latest submission status date: 2023-02-10 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Prescription
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.